ES2193206T3 - Proteinas de plasma sanguineo tratadas termicamente. - Google Patents
Proteinas de plasma sanguineo tratadas termicamente.Info
- Publication number
- ES2193206T3 ES2193206T3 ES95940359T ES95940359T ES2193206T3 ES 2193206 T3 ES2193206 T3 ES 2193206T3 ES 95940359 T ES95940359 T ES 95940359T ES 95940359 T ES95940359 T ES 95940359T ES 2193206 T3 ES2193206 T3 ES 2193206T3
- Authority
- ES
- Spain
- Prior art keywords
- liofilized
- fibrinogen
- grades
- degrees
- blood plasma
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 102000004506 Blood Proteins Human genes 0.000 title 1
- 108010017384 Blood Proteins Proteins 0.000 title 1
- 210000002381 plasma Anatomy 0.000 title 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 3
- FBPFZTCFMRRESA-ZXXMMSQZSA-N D-iditol Chemical compound OC[C@@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-ZXXMMSQZSA-N 0.000 abstract 2
- 102000008946 Fibrinogen Human genes 0.000 abstract 2
- 108010049003 Fibrinogen Proteins 0.000 abstract 2
- 229940012952 fibrinogen Drugs 0.000 abstract 2
- 239000002202 Polyethylene glycol Substances 0.000 abstract 1
- 241000700605 Viruses Species 0.000 abstract 1
- 230000015271 coagulation Effects 0.000 abstract 1
- 238000005345 coagulation Methods 0.000 abstract 1
- 230000018044 dehydration Effects 0.000 abstract 1
- 238000006297 dehydration reaction Methods 0.000 abstract 1
- 238000009472 formulation Methods 0.000 abstract 1
- 230000008014 freezing Effects 0.000 abstract 1
- 238000007710 freezing Methods 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 229920001223 polyethylene glycol Polymers 0.000 abstract 1
- 238000007669 thermal treatment Methods 0.000 abstract 1
- 230000003253 viricidal effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/10—Transferases (2.)
- C12N9/1025—Acyltransferases (2.3)
- C12N9/104—Aminoacyltransferases (2.3.2)
- C12N9/1044—Protein-glutamine gamma-glutamyltransferase (2.3.2.13), i.e. transglutaminase or factor XIII
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
- A61L2/0005—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts
- A61L2/0011—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts using physical methods
- A61L2/0023—Heat
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
- A61L24/04—Surgical adhesives or cements; Adhesives for colostomy devices containing macromolecular materials
- A61L24/10—Polypeptides; Proteins
- A61L24/106—Fibrin; Fibrinogen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/745—Blood coagulation or fibrinolysis factors
- C07K14/75—Fibrinogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/745—Blood coagulation or fibrinolysis factors
- C07K14/755—Factors VIII, e.g. factor VIII C (AHF), factor VIII Ag (VWF)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Hematology (AREA)
- Epidemiology (AREA)
- Toxicology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biomedical Technology (AREA)
- Biophysics (AREA)
- Gastroenterology & Hepatology (AREA)
- Wood Science & Technology (AREA)
- Surgery (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Pharmacology & Pharmacy (AREA)
- Diabetes (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Materials For Medical Uses (AREA)
Abstract
SE PRODUCE UN FIBRINOGENO LIOFILIZADO QUE ES SOMETIDO A UN TRATAMIENTO TERMICO VIRICIDAL TERMINAL SEVERO PARA INACTIVAR LOS VIRUS PRESENTES, AL TIEMPO QUE SE RETIENEN LAS PROPIEDADES BIOLOGICAS DESEABLES. EN PARTICULAR, EL FIBRINOGENO LIOFILIZADO TIENE UNA SOLUBILIDAD EN AGUA O EN OTRA SOLUCION ACUOSA DE 40 G/L EN MENOS DE 20 MINUTOS A 20 (GRADOS) C, Y UN TIEMPO DE COAGULACION MENOR DE 10 SEGUNDOS CUANDO SE LE EXPONE A AL MENOS 200 U/ML DE TROMBINA. EL PRODUCTO SE PUEDE TRATAR TERMICAMENTE A 80 (GRADOS) C DURANTE 72 HORAS Y A HASTA 100 (GRADOS) C DURANTE 10 HORAS DEPENDIENDO DE LA FORMULACION Y DEL CONTENIDO DE AGUA. EN EL PROCESO DE PRODUCCION, EL PRODUCTO COPRECIPITADO SE LAVA CON UNA SOLUCION DE POLIETILENGLICOL A DE 4 A 10 (GRADOS) C Y UN PH DE 6,8 A 8 A BAJA RESISTENCIA IONICA ANTES DE DESHIDRATARLO POR CONGELACION EN DOS ETAPAS.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9424732.7A GB9424732D0 (en) | 1994-12-08 | 1994-12-08 | Heat treated blood plasma proteins |
Publications (1)
Publication Number | Publication Date |
---|---|
ES2193206T3 true ES2193206T3 (es) | 2003-11-01 |
Family
ID=10765577
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES95940359T Expired - Lifetime ES2193206T3 (es) | 1994-12-08 | 1995-12-08 | Proteinas de plasma sanguineo tratadas termicamente. |
Country Status (10)
Country | Link |
---|---|
US (1) | US5831027A (es) |
EP (1) | EP0804254B1 (es) |
JP (2) | JP4181214B2 (es) |
AT (1) | ATE233576T1 (es) |
CA (1) | CA2206670C (es) |
DE (1) | DE69529845T2 (es) |
DK (1) | DK0804254T3 (es) |
ES (1) | ES2193206T3 (es) |
GB (1) | GB9424732D0 (es) |
WO (1) | WO1996017631A1 (es) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5837519A (en) * | 1996-11-21 | 1998-11-17 | Bayer Corporation | Dry-heat viral inactivation under controlled moisture conditions |
WO1999025782A2 (en) | 1997-11-17 | 1999-05-27 | Haemacure Corporation | Fibrin sealants or adhesives comprising a hyaluronic acid derivative material |
ES2156731B1 (es) * | 1999-05-31 | 2002-02-16 | Grifols Grupo Sa | Utilizacion del acido tranexamico para la preparacion de una composicion de fibrinogeno humano. |
JP2001270900A (ja) * | 2000-03-23 | 2001-10-02 | Nihon Pharmaceutical Co Ltd | フィブリノゲンのウイルス不活化法 |
GB0216001D0 (en) | 2002-07-10 | 2002-08-21 | Nat Blood Authority | Process and composition |
FR2857267B1 (fr) * | 2003-07-09 | 2006-03-10 | Lab Francais Du Fractionnement | Formulation stabilisante et solubilisante pour les proteines cryoprecipitables. |
FR2887883B1 (fr) | 2005-06-29 | 2007-08-31 | Lab Francais Du Fractionnement | Procede de separation des proteines fibrinogene, facteur xiii et colle biologique d'une fraction plasmatique solubilisee et de preparation de concentres lyophilises desdites proteines |
FR2894830B1 (fr) * | 2005-12-19 | 2008-04-04 | Lab Francais Du Fractionnement | Procede d'inactivation virale par chauffage a sec selon la temperature de transition vitreuse |
US9110008B2 (en) * | 2010-07-26 | 2015-08-18 | Los Gatos Research | Method for isotopic analysis of water in bodily fluids |
US20140287044A1 (en) * | 2011-03-04 | 2014-09-25 | Rare Antibody Antigen Supply, Inc. | Fibrin sealant (fibringluraas) consisting of a kit of lyophilized or frozen high concentrate fribinogen |
US10793327B2 (en) | 2017-10-09 | 2020-10-06 | Terumo Bct Biotechnologies, Llc | Lyophilization container and method of using same |
US11754478B2 (en) | 2018-08-16 | 2023-09-12 | Abb Schweiz Ag | Rapid equilibrator for water isotope analysis |
WO2020242552A1 (en) | 2019-03-14 | 2020-12-03 | Terumo Bct Biotechnologies, Llc | Multi-part lyophilization container and method of use |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4456590B2 (en) * | 1981-11-02 | 1989-05-30 | Heat treatment of lyphilized blood clotting factor viii concentrate | |
EP0148843B2 (en) * | 1983-03-21 | 1994-05-04 | Novo Nordisk A/S | A concentrate of the antihemophilic factor viii and a process for producing it |
AT390001B (de) * | 1984-09-28 | 1990-03-12 | Immuno Ag | Verfahren zur inaktivierung von vermehrungsfaehigen filtrierbaren krankheitserregern |
DE3577801D1 (de) * | 1985-08-05 | 1990-06-28 | Immuno Ag | Verfahren zur herstellung von praeparationen auf basis von blutgerinnungsfaktoren. |
CA1293941C (en) * | 1985-11-08 | 1992-01-07 | Maria Erlinda Co-Sarno | Method for preparing antihemophilic factor (ahf) by cold precipitation and for improving solubility of recovered ahf product |
EP0413687A1 (en) * | 1987-05-15 | 1991-02-27 | Alan I. Rubinstein | Sequential improved method for treatment of human blood-clotting factor products |
US5099002A (en) * | 1987-05-15 | 1992-03-24 | University Of Southern California | Sequential improved method for treatment of human blood-clotting factor products |
DK708488D0 (da) * | 1988-12-20 | 1988-12-20 | Nordisk Gentofte | Faktor i praeparat |
USH1509H (en) * | 1989-06-09 | 1995-12-05 | Eran; Harutyun | Heparin enhanced process for separating antihemophilic factor (Factor VIII) and fibronectin from cryoprecipitate |
AT402788B (de) * | 1993-08-03 | 1997-08-25 | Immuno Ag | Virussichere blutgerinnungsfaktor xiii-präparation |
-
1994
- 1994-12-08 GB GBGB9424732.7A patent/GB9424732D0/en active Pending
-
1995
- 1995-12-08 DE DE69529845T patent/DE69529845T2/de not_active Expired - Lifetime
- 1995-12-08 ES ES95940359T patent/ES2193206T3/es not_active Expired - Lifetime
- 1995-12-08 DK DK95940359T patent/DK0804254T3/da active
- 1995-12-08 EP EP95940359A patent/EP0804254B1/en not_active Expired - Lifetime
- 1995-12-08 WO PCT/GB1995/002902 patent/WO1996017631A1/en active IP Right Grant
- 1995-12-08 JP JP51743896A patent/JP4181214B2/ja not_active Expired - Lifetime
- 1995-12-08 US US08/849,498 patent/US5831027A/en not_active Expired - Lifetime
- 1995-12-08 AT AT95940359T patent/ATE233576T1/de active
- 1995-12-08 CA CA002206670A patent/CA2206670C/en not_active Expired - Lifetime
-
2007
- 2007-10-17 JP JP2007270389A patent/JP2008044963A/ja not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
JP2008044963A (ja) | 2008-02-28 |
ATE233576T1 (de) | 2003-03-15 |
US5831027A (en) | 1998-11-03 |
CA2206670A1 (en) | 1996-06-13 |
JPH10510257A (ja) | 1998-10-06 |
AU692018B2 (en) | 1998-05-28 |
EP0804254A1 (en) | 1997-11-05 |
CA2206670C (en) | 2008-02-19 |
DK0804254T3 (da) | 2003-06-30 |
WO1996017631A1 (en) | 1996-06-13 |
JP4181214B2 (ja) | 2008-11-12 |
AU4183296A (en) | 1996-06-26 |
DE69529845D1 (de) | 2003-04-10 |
DE69529845T2 (de) | 2003-12-11 |
GB9424732D0 (en) | 1995-02-08 |
EP0804254B1 (en) | 2003-03-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2193206T3 (es) | Proteinas de plasma sanguineo tratadas termicamente. | |
DE3880292T2 (de) | Ausscheidung von prozesschemikalien aus biologischen gemischen mit halogenierten kohlenwasserstoffen. | |
JP4472672B2 (ja) | 血漿の低温殺菌方法 | |
DE60134334D1 (de) | Elektrochirurgische vorrichtung | |
DE3382042D1 (de) | Sterilisierte plasmanebenprodukte und verfahren zur herstellung. | |
ES2114332T3 (es) | Metodo de tratamiento de una solucion proteinica acuosa para matar los microorganismos contenidos en esta sin causar coagulacion. | |
HRP931496A2 (en) | Process for the preparation of biological preparations not containing (active) viruses | |
ES2042667T3 (es) | Procedimiento para la fabricacion de un preparado de transferina, biologicamente activo, seguro contra virus, de gran pureza. | |
CA1337688C (en) | Stabilization of biological and pharmaceutical products during thermal inactivation of viral and bacterial contaminants | |
ES2113910T3 (es) | Procedimiento para la preparacion de un concentrado de trombina asegurado contra virus. | |
ATE298582T1 (de) | Verfahren zur inaktivierung von viren und lyophilisierung von blutproteinen | |
AU568849B2 (en) | Inactivation of viruses in virus containing protein samples | |
CN104958268A (zh) | 一种水蛭素冻干粉针剂的制备方法 | |
IT1306643B1 (it) | Processo per la preparazione dei composti autoreticolati dell'acidoialuronico e dei suoi derivati ottenibili mediante la tecnica | |
FI96918B (fi) | Koostumus veriplasman stabiloimiseksi pastöroinnin aikana | |
KR880004816A (ko) | 항응고제 및 그의 제조방법 | |
DE19623293C2 (de) | Nicht-immunogene Faktor VIII-enthaltende Zusammensetzung und ein Verfahren zu ihrer Herstellung | |
Viehberger et al. | Ultrastructure of skeletal muscle after CO 2-laser incision | |
AT402151B (de) | Verfahren zur herstellung eines virussicheren biologischen präparates | |
FI109766B (fi) | Menetelmä eskaraasia sisältävän proteolyyttisen seoksen valmistamiseksi | |
DK175644B1 (da) | Fremgangsmåde til stabilisering af biologiske og farmaceutiske midler under inaktivering af virale og bakterielle kontaminanter | |
JPS54122715A (en) | Separation and purification of factor inhibiting mutagenesis of mutagenic agent from cabbage juice | |
DE2702075C2 (de) | Hydrolytisches Enzym und dieses enthaltendes Arzneimittel | |
RU98117264A (ru) | Способ инактивации вируса иммунодефицита человека и других вирусов в плазме крови человека с сохранением функциональной активности белков плазмы крови | |
CA2273924A1 (en) | Inactivation of viruses by incubation with caprylate |